Universe Pharmaceuticals Inc (UPC) — Financial Flexibility Index
Universe Pharmaceuticals Inc (UPC) has a Financial Flexibility Index of -0.57x as of December 2025. Free cash flow of $-7.44 Million (operating CF $-7.61 Million minus capex $169.99K) represents -1% of total liabilities ($13.17 Million). Also explore Universe Pharmaceuticals Inc equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Universe Pharmaceuticals Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Universe Pharmaceuticals Inc across 8 annual periods. Check Universe Pharmaceuticals Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Universe Pharmaceuticals Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Universe Pharmaceuticals Inc. For the full company profile including market capitalisation, see Universe Pharmaceuticals Inc (UPC) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.36x | $-4.71 Million | $-5.05 Million | $13.17 Million | ▲ +12.3% |
| 2024 | -0.41x | $-9.14 Million | $-9.51 Million | $22.45 Million | ▼ -581.2% |
| 2023 | 0.08x | $1.16 Million | $1.12 Million | $13.75 Million | ▲ +191.0% |
| 2022 | -0.09x | $-1.22 Million | $-1.31 Million | $13.10 Million | ▼ -109.1% |
| 2021 | 1.02x | $11.48 Million | $-2.06 Million | $11.21 Million | ▲ +32.8% |
| 2020 | 0.77x | $6.17 Million | $6.12 Million | $8.00 Million | ▼ -68.4% |
| 2019 | 2.44x | $13.29 Million | $13.20 Million | $5.45 Million | ▲ +874.6% |
| 2018 | 0.25x | $4.60 Million | $4.46 Million | $18.40 Million | — |